From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence

Minerva Cardioangiol. 2013 Apr;61(2):243-54.

Abstract

The implementation of methods of the coronary angioplasty was one of the most important achievement in the field of treatment of coronary artery disease. Abluminal biodegradable polymer stents (BDS) and polymer free stent are the newest and the most promising research concerning coronary stent technology. In this article we discuss the perceived need for BDS-polymer free stents, the current clinical evidence, limits and future perspectives.

Publication types

  • Review

MeSH terms

  • Absorbable Implants
  • Biomarkers
  • Biotransformation
  • Clinical Trials as Topic
  • Coronary Stenosis / surgery
  • Drug-Eluting Stents
  • Forecasting
  • Foreign-Body Reaction / etiology
  • Foreign-Body Reaction / prevention & control
  • Humans
  • Multicenter Studies as Topic
  • Percutaneous Coronary Intervention / instrumentation
  • Percutaneous Coronary Intervention / methods
  • Polymers*
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control
  • Randomized Controlled Trials as Topic
  • Stents*
  • Treatment Outcome

Substances

  • Biomarkers
  • Polymers